Daniel Barreto, New Vice President, Compliance Practice at Lachman Consultant Services, Inc.

We are pleased to announce that Daniel Barreto will join Lachman Consultants as Vice President, Compliance Practice, effective December 12, 2016.

Mr. Barreto comes to Lachman Consultants with nearly four decades of extensive international experience in the pharmaceutical industry developing and implementing quality strategies and programs to support a continuous state of compliance and consistent state of inspection readiness. He has held senior-level positions that include Head of Quality and Compliance Insulins, Oncology and Medical Devices at Sanofi-Aventis, Germany and Head of Compliance at Sanofi U.S.; Staff Vice President Quality and Compliance at CR Bard; and Vice President of International cGMP Compliance at Janssen Pharmaceutica NV in Belgium.

Mr. Barreto was awarded a B.S. degree in Biology from the University of Puerto Rico and began his career at the U.S. Food and Drug Administration where he advanced from Laboratory Analyst to Supervisory Consumer Safety Officer during his tenure. At the FDA he managed enforcement through the planning and implementation of inspections and investigations of manufacturers of pharmaceutical and devices, IRBs, clinical investigators and special investigations.

On behalf of Lachman Consultants, we welcome Dan and wish him a long and successful career with Lachman Consultants.

For more than 30 years, Lachman Consultants has been the leader in providing cost-effective consultation and remediation services to the worldwide pharmaceutical, biotechnology, biologic, medical device, diagnostic and dietary supplement industries. With its strong and extensive cadre of consultant specialists and an unparalleled management team, its Compliance, Science & Technology, and Regulatory Practices provide the most expert counsel and array of services available. Lachman Consultants is proud of its tradition of supporting industry efforts to develop and ensure safe, effective and high-quality medical products. It remains committed to helping the industry anticipate and address its challenges through the development and implementation of practical, sustainable and cost-effective solutions based on the integration of scientific principles, evolving regulatory expectations, and technology.